251 related articles for article (PubMed ID: 18335793)
61. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
62. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
[TBL] [Abstract][Full Text] [Related]
63. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
64. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
Oh MK; Winn J; Poordad F
Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
[TBL] [Abstract][Full Text] [Related]
65. Diagnosis and interpretation of steatosis and steatohepatitis.
Burt AD; Mutton A; Day CP
Semin Diagn Pathol; 1998 Nov; 15(4):246-58. PubMed ID: 9845426
[TBL] [Abstract][Full Text] [Related]
66. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
67. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
[TBL] [Abstract][Full Text] [Related]
68. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
69. Morphology of alcoholic liver disease.
Lefkowitch JH
Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
[TBL] [Abstract][Full Text] [Related]
70. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K
J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775
[TBL] [Abstract][Full Text] [Related]
71. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
[TBL] [Abstract][Full Text] [Related]
72. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
73. Hepatic steatosis in chronic hepatitis B: contributing factors and effect on fibrosis.
Elloumi H; Hefaiedh R; Gargouri D; Chedly-Debbiche A; Khayat O; Bel Hadj N; Kharrat J; Ghorbel A
Tunis Med; 2008 Nov; 86(11):1000-3. PubMed ID: 19213493
[TBL] [Abstract][Full Text] [Related]
74. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
Ong J; Younossi ZM
Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
[TBL] [Abstract][Full Text] [Related]
75. [The role of liver biopsy in the diagnosis of autoimmune hepatitis].
Szabó Z
Orv Hetil; 2006 Sep; 147(35):1697-702. PubMed ID: 17051746
[TBL] [Abstract][Full Text] [Related]
76. Final results of a long-term, clinical follow-up in fatty liver patients.
Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
[TBL] [Abstract][Full Text] [Related]
77. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.
Clouston AD; Jonsson JR; Powell EE
Clin Liver Dis; 2007 Feb; 11(1):173-89, x. PubMed ID: 17544978
[TBL] [Abstract][Full Text] [Related]
78. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.
Skoien R; Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; O'Brien PE; Tilg H; Moschen AR; Baumann U; Brown RM; Couper RT; Manton ND; Ee LC; Weltman M; Clouston AD
Liver Int; 2013 Apr; 33(4):624-32. PubMed ID: 23356584
[TBL] [Abstract][Full Text] [Related]
79. [Steatosis of the liver cells--subclinical liver damage or more?].
Metzner C; Kirsch WD; Haupt R; Thierbach V
Z Gesamte Inn Med; 1977 Feb; 32(3):78-81. PubMed ID: 857448
[TBL] [Abstract][Full Text] [Related]
80. [Fatty liver disease--mechanism, clinical significance and factors with a special regard to primary hepatotropic viruses].
Smoliński P; Simon K; Gładysz A; Nowak M; Dolińska-Krajewska B
Wiad Lek; 2006; 59(11-12):834-41. PubMed ID: 17427501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
